Peripheral T-cell lymphoma. A clinicopathologic study of a morphologically diverse entity. 1985

D D Weisenburger, and R N Astorino, and F J Glassy, and C H Miller, and M R MacKenzie, and V Caggiano

We analyzed the clinicopathologic features of 13 patients with immunologically confirmed peripheral T-cell lymphoma. The lymphomas were classified into poorly differentiated lymphocytic, mixed cell, and large cell types. Marked morphologic heterogeneity was noted within the mixed cell and large cell categories, and the various subtypes are described. Twelve of the 13 patients received multiagent chemotherapy. Only three of the nine patients with poorly differentiated or mixed cell lymphomas achieved a complete remission, and the median survival for this group was 11 months. In contrast, all three of the treated patients with large cell lymphomas achieved a complete remission, two of whom are alive without disease (14 and 29 months, respectively). Classification of peripheral T-cell lymphomas into lymphocytic, mixed cell, and large cell types, as well as further subclassification within the heterogeneous groups, is suggested so that pathologic features of prognostic significance can be identified.

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

D D Weisenburger, and R N Astorino, and F J Glassy, and C H Miller, and M R MacKenzie, and V Caggiano
September 1996, Leukemia & lymphoma,
D D Weisenburger, and R N Astorino, and F J Glassy, and C H Miller, and M R MacKenzie, and V Caggiano
March 1983, American journal of clinical pathology,
D D Weisenburger, and R N Astorino, and F J Glassy, and C H Miller, and M R MacKenzie, and V Caggiano
January 1987, Hematological oncology,
D D Weisenburger, and R N Astorino, and F J Glassy, and C H Miller, and M R MacKenzie, and V Caggiano
July 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
D D Weisenburger, and R N Astorino, and F J Glassy, and C H Miller, and M R MacKenzie, and V Caggiano
March 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
D D Weisenburger, and R N Astorino, and F J Glassy, and C H Miller, and M R MacKenzie, and V Caggiano
December 1996, Blood,
D D Weisenburger, and R N Astorino, and F J Glassy, and C H Miller, and M R MacKenzie, and V Caggiano
January 1986, Sangre,
D D Weisenburger, and R N Astorino, and F J Glassy, and C H Miller, and M R MacKenzie, and V Caggiano
May 1991, Cancer,
D D Weisenburger, and R N Astorino, and F J Glassy, and C H Miller, and M R MacKenzie, and V Caggiano
January 1989, Japanese journal of medicine,
D D Weisenburger, and R N Astorino, and F J Glassy, and C H Miller, and M R MacKenzie, and V Caggiano
May 1990, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Copied contents to your clipboard!